The Texas Regulatory Efficiency Office (TREO) has released a draft regulatory review proposing the amendment or repeal of 13 rules within the Texas Optometry Board (TOB). According to the project draft, the overhaul would cut 4,251 words from the state administrative code.
The reduction presents a significant optimization opportunity for eye care practices, with estimated annual economic savings ranging from $13.6 million to $39.8 million.
The proposal is part of a multi-phase evaluation conducted jointly by TREO and the TOB to eliminate bureaucratic red tape across state agencies. This entire study was powered by an analytical partnership between TREO and Vulcan Technologies, whose advanced AI platform automated the extensive screening and redlining of the administrative code.
By modernizing prescriptive language and removing redundant administrative burdens, state officials intend to significantly lower compliance overhead for eye care professionals while maintaining strict patient safety standards.
A major contributor to the projected financial savings involves modernizing clinical technology and patient record documentation, which combined account for roughly 83% of the conservative savings estimate. The draft text removes instrument-specific mandates and eliminates legacy prohibitions on digital imaging.
Under the proposed framework, advanced diagnostic tools like digital fundus imaging, optical coherence tomography (OCT), and ultra-widefield imaging are recognized as valid primary examination modalities, allowing clinicians to reduce redundant dual-modality tests when clinically appropriate.
The state also proposes to ease strict documentation formats and paper-printing mandates under 22 TAC §277.7. The draft replaces prescriptive data fields with outcome-oriented standards. For example, instead of requiring specific instrument notations, the updated rule simply requires doctors to record the clinical finding itself.
Regarding prescription release and verification, the proposal updates electronic signature rules to align with the Texas Uniform Electronic Transactions Act and explicitly authorizes the delivery of prescriptions via electronic transmission. It also expands verification channels to accept standard telephone or electronic communication.
For the state’s 1,389 optometric glaucoma specialists, the proposal consolidates complex controlled substance guidelines by cross-referencing federal DEA regulations and the Texas Controlled Substances Act instead of maintaining duplicate rules. The package also introduces clinical delegation flexibilities, removing the requirement that a physician be physically present when trained staff perform delegable tasks. This shift directly accommodates modern telehealth-enabled and multi-location satellite practice models.
While many of these administrative revisions can be executed directly by the state board, broader modernization goals will require the Texas Legislature to take action to codify the legal flexibilities and statutory savings outlined in the report. The upcoming 90th Legislative Session, scheduled to begin in January 2027, will give lawmakers the opportunity to finalize these structural rollbacks into statute.